Efficacy of Celsi Warmer for the Management of Hypothermic Newborns

Not Applicable

Recruiting

• Conditions: Newborn Hypothermia
• Interventions: Device: Celsi Warmer

• Registration Number: NCT06000826
• Lead Sponsor: William Marsh Rice University

Brief Summary

The purpose of the study is to evaluate the efficacy of a novel low-cost warming device to provide thermal care for newborn babies with hypothermia in low-resource hospitals. During the study, research participants will receive thermal care via the Celsi Warmer. Aside from thermal treatment, research participants will receive the standard of care from the neonatal unit, and will also be closely monitored by study personnel throughout the study. The results from this study will allow us to determine if the Celsi Warmer is an effective tool for warming and monitoring newborns in wards of low-resource hospitals. The research team hopes to demonstrate that the Celsi Warmer is effective for the appropriate treatment of newborn hypothermia in hospitals in low-resource settings.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-09-27
• Study First Submitted: 2023-05-31
• Status Verified: 2023-08
• Study First Submitted QC: 2023-08-15
• Last Update Submitted: 2023-08-18
• Study First Posted: 2023-08-21
• Last Update Posted: 2023-08-22
• Primary Completion: 2024-08-20
• Study Completion: 2024-08-20

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

• Is currently being treated at study location

• Is an inborn admission to the neonatal ward

• Whose parents or guardians provided a written informed consent

• Whose parents or guardians providing informed consent are 18 years old or older

• Has a current weight of greater than or equal to 1.0 kg and less than or equal to 4.0kg

• Has been identified as in need of thermal care defined as having a moderate hypothermic temperature (32.0-36.0°C) as the last temperature recorded in hospital chart, or during recruitment procedures; and

• Is unable to be enrolled in KMC for reasons including, but not limited to:

  1. Mother/guardian unable or unavailable to provide KMC
  2. Under observation in NICU before transfer to KMC
  3. No space in KMC
  4. Clinician's discretion

• May be receiving other medical treatments, including but not limited to, CPAP, oxygen therapy, IV fluids, management and monitoring of common newborn conditions such as hypoglycemia, and/or hyperbilirubinemia via LED phototherapy

Exclusion Criteria

• Requires mechanical ventilation

• deemed in need of intensive care by the hospital staff who is providing care,including but not limited to:

  1. Neonates with severe anemia and/or any suspected hematological disorders, and/or
  2. Neonates with obvious congenital anomalies, and/or
  3. neonates suspected with hypo/hyperthyroidism or any hormonal disorders

• Has been diagnosed with birth asphyxia

• Presents a condition that precludes the use of the temperature sensor and/or abdominal belt including but not limited to, gastroschisis, known umbilical cord infection, known skin infection

• Whose clinician presents concerns about their participation

• Is receiving treatment that participation in the study would interfere with, i.e.transferring to KMC

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Neonatal	Celsi Warmer	* A trained study nurse or clinician will transfer the enrolled participant to the study location and place the infant on the Celsi Warmer mattress. * A trained study nurse or clinician will attach the Celsi Warmer temperature sensor to the abdomen and secure it with the abdominal belt according to the device's instruction manual * A trained study nurse or clinician will wrap the baby according to the standard care at the hospital. * Study personnel may observe the participant during the intervention period and annotate timestamped events that might affect temperature measurement and/or thermoregulation support intervention. * Study personnel will perform routine abdominal skin assessments as often as every two hours and at least every 8 hours to observe for skin irritation or indentation. * Thermoregulation support intervention will be provided as long as the infant continues to meet criteria for continued care at clinician's discretion.

Primary Outcome Measures

Name	Time	Method
Broad Objective - Comparison to the Gold Standard of Rewarming Hypothermic Newborns	1 year	To evaluate the clinical efficacy and safety of the Celsi Warmer in rewarming hypothermic newborns by comparing the Celsi Warmer's accuracy in measuring neonatal temperature compared to the gold standard, axillary temperature readings.

Secondary Outcome Measures

Name	Time	Method
Efficacy of the Device	1 year	To assess the performance of the Celsi Warmer in rewarming hypothermic newborns by measuring the incidence of attainment of normothermia (36.5-37.5°C)
Safety of the Device - Measure of Infant's Increase in Temperature	1 year	To measure the infant's rate of temperature (°C) increase through thermoregulatory intervention.
Safety of the Device - Local Effect of the Abdominal Belt	1 year	To evaluate the local effect of the abdominal belt on newborn's skin by looking at any evidence of skin irritation
Safety of the Device - Incidence of Hyperthermia	1 year	To evaluate any incidence of hyperthermia (\>37.5°C) during the thermoregulation intervention.
Safety of the Device - Incidence of Rebound Hypothermia	1 year	To report any incidence of rebound hypothermia ( \< 36.5°C) (post-intervention hypothermia) up to 72 hours from the initial encounter.

Trial Locations

Locations (1)

Muhimbili University of Health and Allied Sciences (MUHAS); 🇹🇿 Dar Es Salaam, Tanzania